The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 Jul 2016 10:48

RNS Number : 9417D
Sopheon PLC
12 July 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Sopheon Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

DevFactory FZ-LLC

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

(a) 5% & 4% - 5 May 2016

(b) 3% - 9 June 2016

6. Date on which issuer notified:

13 June 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

5%, 4% and 3%

 

8. Notified details:

 

A: Voting rights attached to shares viii, ix

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

 

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

 

Direct

Direct xi

Indirect xii

Direct

Indirect

 

GB00BSZM1369

377,500

377,500

272,500

272,500

272,500

3.74%

3.74%

 

GB00BSZM1369

272,500

272,500

0

0

0

0%

0%

 

B: Qualifying Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

 

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 

now 0 (formerly 377,500)

now 0% (formerly 5.18%)

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Mr Joseph Liemandt of Austin, Texas, USA

holds 100% beneficial ownership of DevFactory FZ-LLC

14. Contact name:

Rahul Subramaniam

15. Contact telephone number:

+971 4 4489298

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLAKBDQCBKKOOD
Date   Source Headline
6th Sep 20077:00 amPRNHalf-yearly Report
17th Aug 200710:02 amRNSAIM Rule 26
13th Aug 20077:00 amPRNRe Agreement
19th Jul 20077:00 amPRNTrading Update
10th Jul 20077:01 amRNSGlatfelter Partnership
9th Jul 20077:00 amPRNInvestment in Partner
29th Jun 200710:15 amPRNDirectors' Options
29th Jun 20077:00 amRNSTotal Voting Rights
22nd Jun 200712:04 pmPRNAcquisition Update
18th Jun 20072:30 pmBUSChurch & Dwight Chooses Accolade(R) to Enhance Product Innovation and Portfolio Management
18th Jun 20077:00 amPRNContract Win
11th Jun 20072:30 pmBUSSopheon Announces Agreement to Acquire Alignent Software
11th Jun 20077:00 amPRNAGM Statement
11th Jun 20077:00 amPRNAcquisition
22nd May 20077:00 amPRNContract Win
16th May 20072:30 pmBUSSABMiller plc Taps Sopheon to Power Global Innovation Process Initiative
16th May 20078:18 amPRNContract Win
10th May 20077:00 amPRNProduct Launch
2nd May 20077:00 amPRNQ1 Trading Update
20th Apr 200710:23 amRNSDirector/PDMR Shareholding
29th Mar 20077:00 amPRNFinal Results
27th Mar 20072:45 pmBUSWinbond Israel Advances New Product Innovation with Sopheon's Accolade(R)
27th Mar 20077:00 amPRNContract Win
20th Mar 20071:45 pmBUSLand O'Lakes to Deploy Sopheon's Product Life Cycle Management Solution
20th Mar 20077:00 amPRNContract Win
25th Jan 20077:00 amPRNDirector/PDMR Shareholding
24th Jan 20073:57 pmPRNSchedule 10
19th Jan 20077:00 amPRNTrading Update
29th Dec 20067:00 amRNSTotal Voting Rights
20th Oct 20067:01 amRNSMicrosoft Project Server
20th Oct 20067:00 amPRNTrading Update
19th Oct 20067:01 amRNSTop 40 Software Vendor
13th Oct 20062:28 pmPRNOption Exercise
12th Sep 20067:00 amPRNOrangina Contract Win
31st Aug 20067:00 amPRNInterim Results
21st Jul 20067:00 amPRNTrading Update
12th Jul 20067:01 amRNSContract
16th Jun 20067:00 amPRNAGM Statement
14th Jun 20067:00 amPRNTimex Contract Win
12th Jun 20062:30 pmPRNAdditional Listing
10th May 200610:00 amPRNAdditional Listing
3rd May 20067:00 amPRNGrant of Options
19th Apr 20064:30 pmPRNAdditional Listing
19th Apr 20067:00 amPRNElectrolux Contract Win
18th Apr 20067:00 amPRNFinal Results
10th Apr 20067:00 amPRNContract Win
5th Apr 20067:00 amPRNNotice of Results
21st Mar 20067:00 amPRNFrench Joint Venture
2nd Mar 20067:03 amRNSContract Win
31st Jan 20067:02 amRNSIndustry Recognition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.